Indianapolis, Indiana-based Corteva, Inc. (CTVA) provides agricultural products and develops and supplies germplasm and traits in the corn, soybean, and sunflower seed markets. With a market cap of $49.1 billion, the company operates through two segments, Seed and Crop Protection.
Companies worth $10 billion or more are generally described as "large-cap stocks." CTVA fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the Agricultural Inputs industry. The company benefits from serving the agricultural input industry in the United States, Canada, Latin America, the Asia-Pacific region, Europe, and other global markets.
Shares of the company touched their 52-week high of $72.39 on the last trading session. Shares of CTVA have surged 18.8% over the past three months, outperforming the Materials Select Sector SPDR Fund’s (XLB) 3.4% growth over the same time frame.
Longer term, CTVA stock is up 25.6% on a YTD basis, significantly outperforming XLB’s 5.7% rise. Moreover, shares of the company have surged 38.4% over the past 52 weeks, compared to XLB’s marginal decline over the same time frame.
To confirm its bullish trend, CTVA has been trading above its 200-day moving average since mid-April and above its 50-day moving average since late April.
On May 7, CTVA stock rose marginally following the release of its Q1 earnings. The company reported a 1.7% year-over-year decline in revenue, which totaled $4.4 billion, primarily due to lower net sales across both of its reportable segments, and fell short of consensus estimates. Its adjusted EBITDA rose 15% year-over-year to $1.2 billion. Moreover, CTVA’s adjusted earnings improved 27% year-over-year to $1.13 and beat the Street’s estimates by 29.9%.
In the Agricultural Inputs arena, rival CF Industries Holdings, Inc. (CF) has surged 8% in 2025 and 17.1% in the past 52 weeks, lagging behind the stock.
Among the 21 analysts covering the CTVA stock, the consensus rating is a “Strong Buy.” Its mean price target of $73.53 suggests a 2.8% upside potential from current price levels.
